1. Home
  2. SGRP vs QTTB Comparison

SGRP vs QTTB Comparison

Compare SGRP & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGRP
  • QTTB
  • Stock Information
  • Founded
  • SGRP 1967
  • QTTB 2015
  • Country
  • SGRP United States
  • QTTB United States
  • Employees
  • SGRP N/A
  • QTTB N/A
  • Industry
  • SGRP Business Services
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGRP Consumer Discretionary
  • QTTB Health Care
  • Exchange
  • SGRP Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • SGRP 28.2M
  • QTTB 23.3M
  • IPO Year
  • SGRP 1996
  • QTTB N/A
  • Fundamental
  • Price
  • SGRP $1.18
  • QTTB $1.67
  • Analyst Decision
  • SGRP
  • QTTB Hold
  • Analyst Count
  • SGRP 0
  • QTTB 8
  • Target Price
  • SGRP N/A
  • QTTB $24.00
  • AVG Volume (30 Days)
  • SGRP 294.4K
  • QTTB 104.5K
  • Earning Date
  • SGRP 08-14-2025
  • QTTB 11-06-2025
  • Dividend Yield
  • SGRP N/A
  • QTTB N/A
  • EPS Growth
  • SGRP N/A
  • QTTB N/A
  • EPS
  • SGRP N/A
  • QTTB N/A
  • Revenue
  • SGRP $143,501,000.00
  • QTTB N/A
  • Revenue This Year
  • SGRP $7.22
  • QTTB N/A
  • Revenue Next Year
  • SGRP N/A
  • QTTB N/A
  • P/E Ratio
  • SGRP N/A
  • QTTB N/A
  • Revenue Growth
  • SGRP N/A
  • QTTB N/A
  • 52 Week Low
  • SGRP $0.91
  • QTTB $1.35
  • 52 Week High
  • SGRP $2.48
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • SGRP 52.52
  • QTTB 42.51
  • Support Level
  • SGRP $1.14
  • QTTB $1.62
  • Resistance Level
  • SGRP $1.22
  • QTTB $1.82
  • Average True Range (ATR)
  • SGRP 0.07
  • QTTB 0.16
  • MACD
  • SGRP -0.00
  • QTTB -0.02
  • Stochastic Oscillator
  • SGRP 26.56
  • QTTB 10.42

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: